160 Health International (FRA:O66) Retained Earnings: €-125.79 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:O66 160 Health International Ltd FRA:O66
8 GF Score
Price €1.06
! 5 Warning Signs
View Full Analysis

What is 160 Health International Retained Earnings?

160 Health International FRA:O66 -5.84% 8 Retained Earnings is €-125.79 Mil as of Dec. 2025. GuruFocus rates FRA:O66 with a GF Score™ of 8/100. The stock has 5 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. 160 Health International's retained earnings for the quarter that ended in Dec. 2025 was €-125.79 Mil.

160 Health International's quarterly retained earnings increased from Dec. 2024 (€-126.50 Mil) to Jun. 2025 (€-118.76 Mil) but then declined from Jun. 2025 (€-118.76 Mil) to Dec. 2025 (€-125.79 Mil).

160 Health International's annual retained earnings declined from Dec. 2023 (€-110.03 Mil) to Dec. 2024 (€-126.50 Mil) but then increased from Dec. 2024 (€-126.50 Mil) to Dec. 2025 (€-125.79 Mil).


160 Health International  (FRA:O66) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


160 Health International Retained Earnings Historical Data

* Premium members only.

The historical data trend for 160 Health International's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

160 Health International Retained Earnings Chart

160 Health International Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Retained Earnings
-101.27 -110.03 -126.50 -125.79

160 Health International Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Retained Earnings Get a 7-Day Free Trial -110.03 0.00 -126.50 -118.76 -125.79
FRA:O66
8GF Score
160 Health International Ltd FRA:O66
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

160 Health International Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of €-125.79 Mil mean?
160 Health International (FRA:O66) has a Retained Earnings of €-125.79 Mil as of Dec. 2025. Retained earnings is the amount of net income not issued to shareholders. View historical data on 160 Health International and its competitors.
Is 160 Health International's Retained Earnings too high?
160 Health International's current Retained Earnings is €-125.79 Mil. Overall, 160 Health International has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does 160 Health International's Retained Earnings compare to MCK and COR?
160 Health International's Retained Earnings of €-125.79 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Distribution company?
A good Retained Earnings depends on the Medical Distribution industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on 160 Health International and its competitors. 160 Health International's current Retained Earnings is €-125.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 160 Health International stock overvalued right now?
160 Health International (FRA:O66) has a current Retained Earnings of €-125.79 Mil. The current Retained Earnings is €-125.79 Mil. 160 Health International's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For 160 Health International (FRA:O66), the current Retained Earnings is €-125.79 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

160 Health International Business Description

Other Exchanges 02656:Hong Kong
Address 4078 Dongbin Road, Nanshan Street, 9th, 11th - 12th Floor, Building 2, Yongxin Times Square, Nanshan District, Shenzhen, CHN, 518052
160 Health International Ltd is an experienced pharmaceutical and healthcare product wholesaler and a digital healthcare integrated service provider in China. The company offers a wide assortment of high-quality pharmaceutical and healthcare products under both wholesale and retail models, to address a spectrum of customer needs. In addition, through its online healthcare and wellness service platform, Healthcare 160 Platform. It also provide digital healthcare and wellness solutions, empowering each Platform Participants, including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, throughout the healthcare value chain and driving the digital transformation of China's healthcare and wellness industry.
8GF Score

Get the complete analysis for FRA:O66

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.06
Price